Psychotic Disorders Clinical Trial
— PHYSICO-DSM-VROfficial title:
PHYSICO-DSM-VR - Physical Co-morbidity, Poor Health Behaviour and Health Promotion in Verona Patients With Functional Psychoses: a Prevalence Study and a Randomised Controlled Study
Verified date | June 2016 |
Source | Azienda ULSS di Verona e Provincia |
Contact | n/a |
Is FDA regulated | No |
Health authority | Italy: Ethics Committee |
Study type | Interventional |
The study evaluates the efficacy of health promotion strategies on diet and physical activity in patients with psychosis. Half of the participants will receive an intervention protocol based on education and behavioural change, while half will not receive it.
Status | Completed |
Enrollment | 325 |
Est. completion date | March 2014 |
Est. primary completion date | January 2014 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years to 65 Years |
Eligibility |
Inclusion Criteria: - ICD-10 diagnosis of affective or non-affective functional psychosis (codes F20-22, F24, F25, F28-F31, F23.3, F33.3) - one or more contacts with the CMHS in the 3 months preceding the beginning of the recruitment - Age 18-65 Exclusion Criteria: - moderate or severe mental handicap (learning disability) - organic brain disorders - lack of capacity to consent to inclusion - subjects already involved in individual treatment related to diet and physical exercise - subjects deemed unable or unfit to participate in the proposed physical activities |
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention
Country | Name | City | State |
---|---|---|---|
Italy | UOC 4° Servizio Psichiatria - ULSS 20 | San Bonifacio | Verona |
Italy | UOC 1° Servizio Psichiatria - ULSS 20 | Verona | |
Italy | UOC 2° Servizio Psichiatria - ULSS 20 | Verona | |
Italy | UOC 3° Servizio Psichiatria - ULSS 20 | Verona |
Lead Sponsor | Collaborator |
---|---|
Azienda ULSS di Verona e Provincia | FONDAZIONE CARIVERONA, Universita di Verona |
Italy,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in the number of participants that comply with WHO recommendations on diet and/or exercise | Following the criteria proposed by World Health Organization for a healthy lifestyle: at least 5 servings of fruit/vegetables per day and at least 30 minutes of moderate physical activity per day 5 days a week. Achieving at least one more criterion than baseline at follow up is considered a success. | baseline, month 1, month 2, month 3, month 4, month 5 and month 6 | No |
Secondary | Physical examination | Physical examination by psychiatrist | baseline | No |
Secondary | Long term chronic disease inventory (items 2.1-2.24; MOD.ISTAT/IMF-8/B.04-05-ISTAT) | Questionnaire assessing chronic diseases, administered by investigators | baseline | No |
Secondary | Change in blood pressure | baseline, month 1, month 2, month 3, month 4, month 5 and month 6 | No | |
Secondary | Change in pulses | baseline, month 1, month 2, month 3, month 4, month 5 and month 6 | No | |
Secondary | Change in Body Mass Index | baseline, month 1, month 2, month 3, month 4, month 5 and month 6 | No | |
Secondary | Change in waist circumference | baseline, month 1, month 2, month 3, month 4, month 5 and month 6 | No | |
Secondary | Change in glycemia | baseline and month 6 | No | |
Secondary | Change in haemoglobin A1C | baseline and month 6 | No | |
Secondary | Change in LDL cholesterol | baseline and month 6 | No | |
Secondary | Change in HDL cholesterol | baseline and month 6 | No | |
Secondary | Change in triglyceridemia | baseline and month 6 | No | |
Secondary | Electrocardiogram | baseline | No | |
Secondary | Medication History Schedule | Ad hoc form filled in by psychiatrist on present and previous psychopharmacological or non psychopharmacological medications taken by the participant | baseline | No |
Secondary | 36 Item Short Form Health Survey | beginning and month 6 | No | |
Secondary | Verona Service Satisfaction Scale - European Version | beginning and month 6 | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05321602 -
Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder
|
Phase 1 | |
Terminated |
NCT03230097 -
This Study Tests Whether BI 409306 Prevents Patients With a Specific Type of Mental Illness (Attenuated Psychosis Syndrome) From Becoming Worse. This Study Looks at How Well Patients Tolerate the Medicine and How Effective it is Over 1 Year
|
Phase 2 | |
Completed |
NCT03497663 -
VIA Family - Family Based Early Intervention Versus Treatment as Usual
|
N/A | |
Active, not recruiting |
NCT05726617 -
Avatar Intervention for the Treatment of Cannabis Use Disorder in Patients With Severe Mental Health Disorders
|
N/A | |
Not yet recruiting |
NCT03807388 -
ReMindCare App for Patients From First Episode of Psychosis Unit.
|
N/A | |
Recruiting |
NCT02874573 -
Tocilizumab in Schizophrenia
|
Phase 1 | |
Completed |
NCT02906553 -
The Role of Nitric Oxide in Cognition in Schizophrenia
|
N/A | |
Terminated |
NCT02584114 -
Brain Effects of Memory Training in Early Psychosis
|
N/A | |
Terminated |
NCT02841956 -
Reducing Duration of Untreated Psychosis Through Rapid Identification and Engagement
|
N/A | |
Withdrawn |
NCT02213887 -
Study of the Effects of Pantoprazole on Levels of Prescribed Psychiatric Medications
|
Phase 4 | |
Completed |
NCT01981356 -
Acceptance and Commitment Therapy for the Inpatient Treatment of Psychosis
|
Phase 0 | |
Recruiting |
NCT02848469 -
Irish Omega-3 Study
|
Phase 2 | |
Recruiting |
NCT02009969 -
Serial Comparisons of Abdominal and Neurological MRI Scans
|
N/A | |
Completed |
NCT02648321 -
Motivational Intervention for Physical Activity in Psychosis
|
N/A | |
Enrolling by invitation |
NCT00762866 -
Psychiatric Genotype/Phenotype Project Repository
|
||
Completed |
NCT00484302 -
Specialized Addiction Treatment Versus Treatment as Usual for Young Patients With Cannabis Abuse and Psychosis
|
N/A | |
Completed |
NCT00455234 -
Rapid Tranquillization Trial: TREC-India II
|
Phase 3 | |
Completed |
NCT00844922 -
Safety of Org 34517 900 mg in Patients Who Received Org 34517 in a Previous Trial (Study 28133/P05842)
|
Phase 2 | |
Completed |
NCT00130923 -
Risperidone Long-acting Versus Oral Risperidone in Patients With Schizophrenia and Alcohol Use Disorder
|
Phase 4 | |
Completed |
NCT00226278 -
Safety Study of ORG 34517 for Major Depression With Psychotic Features
|
Phase 2 |